Bronchodilator responses to nebulised ipratropium and salbutamol singly and in combination in chronic bronchitis.
- 1 January 1984
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 17 (1) , 103-105
- https://doi.org/10.1111/j.1365-2125.1984.tb05008.x
Abstract
A placebo controlled study compared the magnitude and duration of bronchodilatation produced by nebulised salbutamol (5 mg) and ipratropium (0.5 mg) singly and in combination in twenty patients with chronic bronchitis (mean baseline FEV1 was 33% predicted). The onset of action, of both nebulised salbutamol and ipratropium given singly, occurred within 15 min. Both agents produced a similar degree of bronchodilatation. In combination both the magnitude and duration of the bronchodilatation produced was significantly greater than with either agent alone.Keywords
This publication has 6 references indexed in Scilit:
- Comparison of Ipratropium Bromide and Salbutamol by Aerosolized SolutionAustralian and New Zealand Journal of Medicine, 1981
- Synergism between ipratropium and theophylline in asthma.Thorax, 1981
- Ipratropium BromideDrugs, 1980
- Combined Cholinergic Antagonist and β2-Adrenoceptor Agonist Bronchodilator Therapy by InhalationAustralian and New Zealand Journal of Medicine, 1979
- Bronchodilatation and the site of airway resistance in severe chronic bronchitis.Thorax, 1979
- Comparison of ipratropium bromide and fenoterol in asthma and chronic bronchitis.Published by Wiley ,1978